Results 151 to 160 of about 55,015 (188)

Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study. [PDF]

Malar J
Getu E, Biruksew A, Eshetu T, Abamecha A, Assefa DG, Mohammed H, Wuletaw Y, Tasew G, Tollera G, Hailu M, Kassa M, Assefa A, Brhane BG.   +12 more
europepmc   +1 more source

Resurgence of <i>Plasmodium vivax</i> malaria in French Guiana (2023-2024): a multifactorial crisis in the Amazonian region-response to Salazar et al. [PDF]

Lancet Reg Health Am
Epelboin L, Oberlis M, Lambert Y, Carvalho L, Douine M.   +4 more
europepmc   +1 more source

Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study. [PDF]

Lancet
Weiss DJ, Dzianach PA, Saddler A, Lubinda J, Browne A, McPhail M, Rumisha SF, Sanna F, Gelaw Y, Kiss JB, Hafsia S, Jayaseelen R, Baggen HS, Amratia P, Bertozzi-Villa A, Nesbit O, Whisnant J, Battle KE, Nguyen M, Alene KA, Cameron E, Penny MA, Bhatt S, Smith DL, Symons TL, Mosser JF, Murray CJL, Hay SI, Gething PW.   +28 more
europepmc   +1 more source

Genomic analysis of global Plasmodium vivax populations reveals insights into the evolution of drug resistance. [PDF]

Nat Commun
Ngwana-Joseph GC, Phelan JE, Manko E, Dombrowski JG, da Silva Santos S, Suarez-Mutis M, Vélez-Tobón G, Tobón Castaño A, Machado RLD, Marinho CRF, Nolder D, Nosten F, Sutherland CJ, Campino S, Clark TG.   +14 more
europepmc   +1 more source

Challenges in managing gestational malaria due to Plasmodium vivax with severe complications: A clinical case from Colombia. [PDF]

IJID Reg
Tovar-Acero C, Bolívar Pineda CA, Pérez Vergara ED, Díaz Cornejo N, Ricardo-Caldera D.   +4 more
europepmc   +1 more source

Characteristics of Plasmodium vivax apicomplexan amino acid transporter 8 (PvApiAT8) in the cationic amino acid transport. [PDF]

Sci Rep
Lee WJ, Mazigo E, Han JH, Cha SH.
europepmc   +1 more source

Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa. [PDF]

PLoS One
Balam S, Miura K, Ayadi I, Konaté D, Incandela NC, Agnolon V, Guindo MA, Diakité SAS, Olugbile S, Nebie I, Herrera SM, Long C, Kajava AV, Diakité M, Corradin G, Herrera S, Herrera MA.   +16 more
europepmc   +1 more source

Plasmodium vivax antigen candidate prediction improves with the addition of Plasmodium falciparum data. [PDF]

NPJ Syst Biol Appl
Chou RT, Ouattara A, Takala-Harrison S, Cummings MP.   +3 more
europepmc   +1 more source

Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial. [PDF]

Proc Natl Acad Sci U S A
Mehra S, Nosten F, Luxemburger C, White NJ, Watson JA.   +4 more
europepmc   +1 more source

UnderstandingPlasmodium vivaxrecurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification

Rosado J, Han J, Obadia T, Munro J, Traore Z, Schoffer K, Brewster J, Bourke C, Vinetz JM, White M, Bahlo M, Gamboa D, Mueller I, Ruybal-Pesántez S.   +13 more
europepmc   +1 more source